UiPath, Inc. (NYSE:PATH – Get Free Report) insider Brad Brubaker sold 27,404 shares of the business’s stock in a transaction that occurred on Monday, October 12th. The stock was sold at an average price of $13.63, for a total transaction of $373,516.52. Following the completion of the sale, the insider owned 1,066,107 shares of the company’s stock, valued at approximately $14,531,038.41. The trade was a 2.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
UiPath Stock Performance
Shares of UiPath stock opened at $13.05 on Thursday. UiPath, Inc. has a 52-week low of $9.20 and a 52-week high of $19.84. The stock has a market capitalization of $6.80 billion, a price-to-earnings ratio of 19.49, a price-to-earnings-growth ratio of 1.24 and a beta of 1.01. The company has a fifty day moving average of $14.75 and a 200-day moving average of $12.36.
UiPath (NYSE:PATH – Get Free Report) last released its earnings results on Thursday, September 3rd. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The company had revenue of $410.26 million for the quarter, compared to analyst estimates of $397.77 million. UiPath had a net margin of 21.03% and a return on equity of 9.70%. The firm’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.15 EPS. On average, equities research analysts forecast that UiPath, Inc. will post 0.49 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on PATH. Bank of America raised their price objective on UiPath from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, September 4th. HC Wainwright reissued a “buy” rating on shares of UiPath in a research note on Friday, September 4th. Wells Fargo & Company boosted their target price on UiPath from $13.00 to $15.00 and gave the company an “equal weight” rating in a research note on Friday, September 4th. Royal Bank Of Canada restated an “outperform” rating on shares of UiPath in a report on Wednesday, September 23rd. Finally, Oppenheimer restated a “market perform” rating on shares of UiPath in a research report on Friday, September 4th. Four investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, UiPath has a consensus rating of “Hold” and an average price target of $15.69.
Get Our Latest Stock Analysis on PATH
Key Headlines Impacting UiPath
Here are the key news stories impacting UiPath this week:
- Positive Sentiment: UiPath’s stock has gained 33% over six months, supported by increased enterprise AI adoption, positive fiscal 2026 net income and improving profitability. Analysts view the company’s valuation as relatively attractive compared with its growth prospects. UiPath Stock Gains 33% in 6 Months
- Positive Sentiment: UiPath continues to generate higher absolute revenue than Figma and is scaling its AI-powered automation platform for global enterprises. Its latest reported quarter also showed 13.3% year-over-year revenue growth and revenue above analyst expectations. C3.ai vs. UiPath
- Neutral Sentiment: Analyst sentiment remains mixed: the consensus rating is “Hold,” with an average price target of $15.69, while individual targets range from $14 to $22. This suggests potential upside but limited conviction across Wall Street.
- Neutral Sentiment: Executive commentary about AI agents, workforce effects and “AI slop” provides industry context but does not represent a new financial catalyst for UiPath. UiPath’s Michael Atalla on AI Agents
- Negative Sentiment: Two insiders sold a combined 56,968 shares worth approximately $773,000. Brad Brubaker reduced his position by 2.51%, while Raghavendra Malpani reduced his by 1.91%; both retained substantial holdings, limiting the severity of the signal but potentially adding selling pressure. Brad Brubaker SEC Filing Raghavendra Malpani SEC Filing
- Negative Sentiment: Revenue growth comparisons show UiPath’s performance has been volatile, with seasonal spikes followed by declines, while Figma has posted consistent quarter-over-quarter growth and is narrowing the revenue gap. This raises concerns about the durability and consistency of UiPath’s growth profile. Figma vs. UiPath Revenue Growth Trends
About UiPath
UiPath, Inc is a software company that develops an enterprise automation platform designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation, artificial intelligence, workflow orchestration, process mining, document processing and application integration tools to support automation across departments and business systems.
UiPath offers products and services for discovering automation opportunities, building and managing software robots, processing documents and other unstructured data, and governing automation programs at scale.
See Also
- Five stocks we like better than UiPath
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
